HEALTH TECHNOLOGIES
Please, select the research line of your interest to have detailed information about it.
Please, select the research line of your interest to have detailed information about it.
Ref. | University | Area · subarea | Key words | Supervisor in hosting research group | |
---|---|---|---|---|---|
UR-FCL | University of La Rioja | Chemical Science and Technology; chemistry | Synthesis of glycopeptides; NMR experiments; molecular dynamic simulations; clinical applications; tumor detection; anticancer vaccines; unnatural antigens; MUC1-like glycopeptides; gold nanoparticles; biofunctionalised nanoparticles; antibody detection; nanoparticle-based vaccine development; mice experimentation. | Francisco Corzana López | Apply |
UR-AGM | University of La Rioja | Agricultural and Agri-food science; food science and technology.Chemical Science and Technology; chemistry. | Food disinfection using direct atmospheric pressure cold plasma; Mechanisms of microbial disinfection of cold plasma; Effects of cold plasma on food quality; Food functionalization using cold plasma; Food contact surface decontamination using cold plasma; Food disinfection using plasma activated water (PAW); Food packaging material processing and in-package food decontamination using cold plasma; Plasma-polymerized functional coatings; Security and safety of cold plasma treated food; Industrial scale-up of cold plasma technology; Data science; Machine learning. | Ana Gonzalez Marcos | Apply |
UR-CDP | University of La Rioja | Information and Communication Technologies; computer science and information technology. | Bioinformatics; machine learning; deep learning; algorithms; computer methods; analysis of digital bioimages; mathematical models; biomedical applications. | Cesar Dominguez Perez | Apply |
UR-CT | University of La Rioja | Biomedicine; immunology, infection and new therapies.Agricultural and Agri-food sciences; Food science and technology, agriculture and farming. | Antibiotic resistance; OneHealth, Humans-Animals-Environment, Resistome and Virulome, Food Security; New Antimicrobials, Antibiotic Resistance Modelling; Antibiotic footprint. | Carmen Torres | Apply |
UR-FA | University of La Rioja | Economy; economy and its applications | Health economics; health care cost analysis; statistical analysis and modelling; informatics models of economic evaluation; chronic diseases; infectious diseases; antibiotics; antimicrobial resistance; epidemiology; life cycle models. | Fernando Antoñanzas | Apply |
UPNA-IM | Public University of Navarre | Information and Communication Technologies; microelectronics, nanotechnology and photonics. | Photonic sensors; biomedical devices; LMR – based optical waveguide sensing platform; detection of DNA or proteins; aqueous environment; Lossy Mode Resonance technology; optical resonators; microfluidic systems; EVs. | Ignacio Matias | Apply |
UPNA-IL | Public University of Navarre | Bioscience and Biotechnology; biotechnology. | Microbial pathogenesis; bacterial gene regulation; signal transduction; biofilms; Bap family proteins; exopolysaccharides; RNA transcription; biotechnology; molecular biology; genetic engineering. | Iñigo Lasa | Apply |
UNIZAR-MR | University of Zaragoza | Chemical Science and Technology; chemistry. | Atomic Spectroscopy; isotopic and elemental analysis; trace levels; biomedical applications; nanotechnology. | Martín Resano | Apply |
UNIZAR-JGB | University of Zaragoza | Chemical Science and Technology; chemistry. | Optical nano biosensors; enzymatic reactions; flavoenzymes; blood clinical parameters (glucose, lipids); continuous monitoring; hemeproteins; biogenic amines; nanomaterials (gold nanoparticles; nanoclusters); theoretical studies; signal modelling; data management; implementation in disposable devices (test strip, lateral flow systems) and smart packaging; digital image detection systems. | Javier Galbán Bernal | Apply |
UDL-DAC | University of Lleida | Biomedicine;Cancer | Molecular oncology; colorectal cancer; genetics; clinical trials; mouse models; patients; therapies; regorafenib; TAS102; predictive biomarker signatures; clinical implementation; microRNA predictors. | Diego Arango del Corro | Apply |